MSD’s Keytruda impresses in lung cancer chemotherapy trial
December 21, 2015Manufacturing and Production, Research and Development MSD, PD-L1, docetaxel, keytruda, lung cancer, non small cell lung cancer, non-small cell lung cancer, pd-1, pembrolizumab
MSD’s Keytruda significantly improved overall survival (OS) compared to chemotherapy in people with lung cancer and PD-L1 expression, a trial …
Novartis completes purchase of rights to GSK drug for up to $1bn
December 21, 2015Manufacturing and Production, Research and Development, Sales and Marketing
Novartis has completed the acquisition of all outstanding rights to Arzerra from GSK for up to $1.034 billion. The deal, …
Experts predict pharma sector to remain strong in 2016
December 21, 2015Sales and Marketing marketing, pharma, profits, sales
The year 2016 is set to see continued growth in research and development productivity, with significant new drug launches and …
ISIS Pharma changes name to Ionis to avoid ‘distracting’ militant association
December 21, 2015Sales and Marketing Ionis, Isis Pharmaceuticals, branding, marketing, rebrand
After months of discussion, ISIS Pharmaceuticals has changed its name to Ionis to free itself from the fear of confusion …
Merck on the march in Africa
December 21, 2015Sales and Marketing Africa, Merck, marketing, sales, strategy
When Merck unveiled its Africa 2020 strategy in November, there was no shortage of ambition.The company announced plans to expand …
Three AstraZeneca drugs recommended by EMA committee
December 21, 2015Sales and Marketing AstraZeneca, Brilique, CHMP, EMA, Portrazza, Tagrisoo, lesinurad, lilly
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended several new drugs in its latest meeting, including …
Martin Shkreli resigns from Turing
December 21, 2015Sales and Marketing Martin Shkreli, Shkreli, Turing Pharmaceuticals
Following his arrest on securities fraud charges, Martin Shkreli has resigned as chief executive of Turing and been replaced by …
Ariad names EMD Serono’s Paris Panayiotopoulos as new president and chief exec
December 21, 2015Sales and Marketing Ariad, Ariad Pharmaceuticals, EMD Serono, Paris Panayiotopoulos, harvey Berger
The board of directors at Ariad Pharmaceuticals has appointed Paris Panayiotopoulos as president and chief executive from 1 January 2016. …
Gilead steps in to rescue Galapagos RA drug
December 18, 2015Sales and Marketing AbbVie, Gilead, Gilead Sciences, filgotinib, inflammation, inflammatory diseases, rheumatoid arthritis
Gilead Sciences is to pay $725million for the rights to filgotinib, a JAK1-selective inhibitor for rheumatoid arthritis and other inflammatory …
European approval for Amgen cancer drug Imlygic
December 18, 2015Sales and Marketing Amgen, European Commission, Imlygic, melanoma, skin cancer, t-vec, talimogene laherparepvec
The European Commission has approved the use of Amgen’s Imlygic for adults with advanced melanoma, making it the first drug …
Karma may have caught up with Martin Shkreli, but America’s drug pricing problem isn’t about one man
December 18, 2015Manufacturing and Production, Sales and Marketing Daraprim, Martin Shkreli, Turing Pharmaceuticals
As so often occurs in situations of this kind, Twitter reacted with a significant amount of glee and schadenfreude to …
Servier UK appoints new chief executive
December 18, 2015Manufacturing and Production, Research and Development, Sales and Marketing Arnaud Lallouette, Mike Sumpter, Servier
Dr Arnaud Lallouette has been appointed chief executive of Servier Laboratories, the UK subsidiary of the French-based pharma firm, after …
Horizon chief exec Walbert to head up US biotech trade body
December 18, 2015Manufacturing and Production, Research and Development, Sales and Marketing Illinois Biotechnology Industry Organisation, Timothy Walbert, iBio, illinois
Timothy Walbert, the chairman, president and chief executive of Horizon Pharma, has been elected as chairman of the board of …
ViiV Healthcare to acquire Bristol-Myers Squibb’s HIV pipeline drugs
December 18, 2015Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, HIV, ViiV, ViiV Healthcare
Specialist HIV company ViiV Healthcare has agreed deals worth up to $1.46 billion to purchase Bristol-Myers Squibb’s late stage HIV …
Astellas investigated for ‘misleading’ PMCPA during ABPI code complaint
December 18, 2015Medical Communications ABPI Code, Astellas, Astellas Pharma Europe, PMCPA, Prescription Medicines Code of Practice Authority
The Prescription Medicines Code of Practice Authority is investigating Astellas for deliberately providing an ‘incomplete and misleading’ response to a …
Prime Medical Group expands senior editorial team
December 17, 2015Medical Communications Prime Medical Group
The Prime Medical Group has announced the appointment of Valerie Moss PhD to the position of editorial & scientific executive …
Alliance Pharma buys Sinclair’s healthcare products business for £132m
December 17, 2015Manufacturing and Production, Sales and Marketing Alliance Pharma, Sinclair IS Pharma, acquisitions, dermatology merger
Alliance has completed a £132 million purchase of Sinclair IS Pharma’s non-aesthetics healthcare business as it moves to strengthen its …
FDA approves Lilly/Boehringer Lantus biosimilar
December 17, 2015Medical Communications, Sales and Marketing Basaglar, Boehringer Ingelheim, Eli Lilly, Lantus, Sanofi, abasaglar, biosimilar, diabetes, insulin, lilly
The FDA has approved Eli Lilly and Boehringer Ingelheim’s long-acting insulin Basaglar (insulin glargine injection – a biosimilar to rival Sanofi’s …
Pharma company accused of ‘bribing’ prescribers slammed by PMCPA
December 17, 2015Medical Communications ABPI Code, Daily Telegraph, PMCPA, Prescription Medicines Code of Practice Authority, Stirling Anglian
Stirling Anglian, the company at the centre of media criticism for arranging meetings at lavish hotels in an attempt to …
Turing chief exec Martin Shkreli arrested
December 17, 2015Medical Communications, Sales and Marketing Daraprim, FBI, Martin Shkreli, Shkreli, turing
Turing chief executive Martin Shkreli has been arrested on a charge of securities fraud relating to a company he founded, …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
